ANIKAnika Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Anika Therapeutics, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIKEsta | $260M#5 | — | 1.9x#3 | 2.3x#5 | -5.9%#10 | 80.4%#3 | -9.8%#6 | -8.0%#6 | -8.8%#4 | 4#6 | 97.6%#1 | — |
| MOBI | $332M#1 | — | 1.9x#4 | — | — | — | — | 0.0%#5 | — | — | — | — |
| CLPT | $311M#2 | — | 11.4x#11 | 8.4x#12 | 17.8%#4 | -35.0%#11 | -65.4%#12 | -93.7%#10 | — | — | -48.9%#7 | — |
| TMCI | $277M#3 | — | 4.1x#6 | 1.3x#2 | 1.6%#8 | -5.8%#8 | -25.5%#8 | -87.1%#9 | -47.4%#8 | 2#9 | -35.3%#6 | — |
| CTSO | $276M#4 | — | — | 7.4x#11 | 4.1%#7 | 60.4%#4 | -39.8%#9 | — | -122.1%#9 | 4#6 | -70.6%#8 | — |
| INFU | $253M#6 | 31.8x#4 | 4.3x#7 | 1.8x#3 | 6.4%#6 | 182.6%#2 | 8.3%#4 | 11.2%#3 | 9.5%#3 | 9#1 | 23.1%#3 | — |
| OSUR | $243M#7 | — | 0.8x#1 | 2.1x#4 | -38.1%#12 | -252.5%#12 | -62.6%#11 | -21.6%#8 | -43.8%#6 | — | 32.7%#2 | — |
| IDXG | $240M#8 | 9.9x#1 | 10.3x#10 | 6.2x#10 | -17.5%#11 | 267.2%#1 | 10.5%#3 | 105.8%#1 | 14.2%#2 | 5#4 | — | — |
| UTMD | $224M#9 | 21.5x#3 | 1.8x#2 | 5.8x#9 | -5.8%#9 | -18.7%#9 | 29.6%#1 | 9.2%#4 | — | — | 22.7%#4 | 1.8%#1 |
| TLSI | $215M#10 | — | 32.9x#12 | 4.8x#8 | 53.4%#2 | -30.6%#10 | -59.7%#10 | -598.9%#12 | — | 5#4 | -25.4%#5 | — |
| PDEX | $194M#11 | 16.7x#2 | 3.9x#5 | 2.5x#6 | 16.5%#5 | 52.2%#6 | 16.8%#2 | 27.7%#2 | 17.9%#1 | 7#2 | — | — |
| STIM | $173M#12 | — | 9.7x#9 | 1.2x#1 | 99.2%#1 | 10.8%#7 | -21.1%#7 | -218.5%#11 | -43.9%#7 | 3#8 | — | — |
| KRMD | $144M#13 | — | 8.0x#8 | 3.5x#7 | 22.2%#3 | 56.5%#5 | -7.2%#5 | -14.6%#7 | -29.4%#5 | 6#3 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice